314 related articles for article (PubMed ID: 37501540)
1. UBQLN2 and HSP70 participate in Parkin-mediated mitophagy by facilitating outer mitochondrial membrane rupture.
Ma Q; Xin J; Peng Q; Li N; Sun S; Hou H; Ma G; Wang N; Zhang L; Tam KY; Dussmann H; Prehn JH; Wang H; Ying Z
EMBO Rep; 2023 Sep; 24(9):e55859. PubMed ID: 37501540
[TBL] [Abstract][Full Text] [Related]
2. Global proteomics of Ubqln2-based murine models of ALS.
Whiteley AM; Prado MA; de Poot SAH; Paulo JA; Ashton M; Dominguez S; Weber M; Ngu H; Szpyt J; Jedrychowski MP; Easton A; Gygi SP; Kurz T; Monteiro MJ; Brown EJ; Finley D
J Biol Chem; 2021; 296():100153. PubMed ID: 33277362
[TBL] [Abstract][Full Text] [Related]
3. Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation.
Wong YC; Holzbaur EL
Proc Natl Acad Sci U S A; 2014 Oct; 111(42):E4439-48. PubMed ID: 25294927
[TBL] [Abstract][Full Text] [Related]
4. Modeling UBQLN2-mediated neurodegenerative disease in mice: Shared and divergent properties of wild type and mutant UBQLN2 in phase separation, subcellular localization, altered proteostasis pathways, and selective cytotoxicity.
Sharkey LM; Sandoval-Pistorius SS; Moore SJ; Gerson JE; Komlo R; Fischer S; Negron-Rios KY; Crowley EV; Padron F; Patel R; Murphy GG; Paulson HL
Neurobiol Dis; 2020 Sep; 143():105016. PubMed ID: 32653673
[TBL] [Abstract][Full Text] [Related]
5. UBQLN2-HSP70 axis reduces poly-Gly-Ala aggregates and alleviates behavioral defects in the C9ORF72 animal model.
Zhang K; Wang A; Zhong K; Qi S; Wei C; Shu X; Tu WY; Xu W; Xia C; Xiao Y; Chen A; Bai L; Zhang J; Luo B; Wang W; Shen C
Neuron; 2021 Jun; 109(12):1949-1962.e6. PubMed ID: 33991504
[TBL] [Abstract][Full Text] [Related]
6. ALS/FTD mutations in UBQLN2 are linked to mitochondrial dysfunction through loss-of-function in mitochondrial protein import.
Lin BC; Phung TH; Higgins NR; Greenslade JE; Prado MA; Finley D; Karbowski M; Polster BM; Monteiro MJ
Hum Mol Genet; 2021 Jun; 30(13):1230-1246. PubMed ID: 33891006
[TBL] [Abstract][Full Text] [Related]
7. Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia.
Renaud L; Picher-Martel V; Codron P; Julien JP
Acta Neuropathol Commun; 2019 Jul; 7(1):103. PubMed ID: 31319884
[TBL] [Abstract][Full Text] [Related]
8. Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants.
Strohm L; Hu Z; Suk Y; Rühmkorf A; Sternburg E; Gattringer V; Riemenschneider H; Berutti R; Graf E; Weishaupt JH; Brill MS; Harbauer AB; Dormann D; Dengjel J; Edbauer D; Behrends C
Life Sci Alliance; 2022 Nov; 5(11):. PubMed ID: 35777956
[TBL] [Abstract][Full Text] [Related]
9. Serpin neuropathology in the P497S UBQLN2 mouse model of ALS/FTD.
Higgins NR; Greenslade JE; Wu JJ; Miranda E; Galliciotti G; Monteiro MJ
Brain Pathol; 2021 Sep; 31(5):e12948. PubMed ID: 33780087
[TBL] [Abstract][Full Text] [Related]
10. Distribution of ubiquilin 2 and TDP-43 aggregates throughout the CNS in UBQLN2 p.T487I-linked amyotrophic lateral sclerosis and frontotemporal dementia.
Nementzik LR; Thumbadoo KM; Murray HC; Gordon D; Yang S; Blair IP; Turner C; Faull RLM; Curtis MA; McLean C; Nicholson GA; Swanson MEV; Scotter EL
Brain Pathol; 2024 May; 34(3):e13230. PubMed ID: 38115557
[TBL] [Abstract][Full Text] [Related]
11. ALS/FTD mutations in UBQLN2 impede autophagy by reducing autophagosome acidification through loss of function.
Wu JJ; Cai A; Greenslade JE; Higgins NR; Fan C; Le NTT; Tatman M; Whiteley AM; Prado MA; Dieriks BV; Curtis MA; Shaw CE; Siddique T; Faull RLM; Scotter EL; Finley D; Monteiro MJ
Proc Natl Acad Sci U S A; 2020 Jun; 117(26):15230-15241. PubMed ID: 32513711
[TBL] [Abstract][Full Text] [Related]
12. Human Ubiquilin 2 and TDP-43 copathology drives neurodegeneration in transgenic Caenorhabditis elegans.
Saxton AD; Kraemer BC
G3 (Bethesda); 2021 Aug; 11(8):. PubMed ID: 33963840
[TBL] [Abstract][Full Text] [Related]
13. Disturbance of proteasomal and autophagic protein degradation pathways by amyotrophic lateral sclerosis-linked mutations in ubiquilin 2.
Osaka M; Ito D; Suzuki N
Biochem Biophys Res Commun; 2016 Apr; 472(2):324-31. PubMed ID: 26944018
[TBL] [Abstract][Full Text] [Related]
14. Axon guidance genes modulate neurotoxicity of ALS-associated UBQLN2.
Kim SH; Nichols KD; Anderson EN; Liu Y; Ramesh N; Jia W; Kuerbis CJ; Scalf M; Smith LM; Pandey UB; Tibbetts RS
Elife; 2023 Apr; 12():. PubMed ID: 37039476
[TBL] [Abstract][Full Text] [Related]
15. The interaction between E3 ubiquitin ligase Parkin and mitophagy receptor PHB2 links inner mitochondrial membrane ubiquitination to efficient mitophagy.
Sun S; Hou H; Ma G; Ma Q; Li N; Zhang L; Dong C; Cao M; Tam KY; Ying Z; Wang H
J Biol Chem; 2022 Dec; 298(12):102704. PubMed ID: 36379251
[TBL] [Abstract][Full Text] [Related]
16. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia.
Deng HX; Chen W; Hong ST; Boycott KM; Gorrie GH; Siddique N; Yang Y; Fecto F; Shi Y; Zhai H; Jiang H; Hirano M; Rampersaud E; Jansen GH; Donkervoort S; Bigio EH; Brooks BR; Ajroud K; Sufit RL; Haines JL; Mugnaini E; Pericak-Vance MA; Siddique T
Nature; 2011 Aug; 477(7363):211-5. PubMed ID: 21857683
[TBL] [Abstract][Full Text] [Related]
17. Ubiquilin 2: a component of the ubiquitin-proteasome system with an emerging role in neurodegeneration.
Zhang KY; Yang S; Warraich ST; Blair IP
Int J Biochem Cell Biol; 2014 May; 50():123-6. PubMed ID: 24589709
[TBL] [Abstract][Full Text] [Related]
18. UBQLN proteins in health and disease with a focus on UBQLN2 in ALS/FTD.
Lin BC; Higgins NR; Phung TH; Monteiro MJ
FEBS J; 2022 Oct; 289(20):6132-6153. PubMed ID: 34273246
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic mutations in UBQLN2 exhibit diverse aggregation propensity and neurotoxicity.
Safren N; Dao TP; Mohan HM; Huang C; Trotter B; Castañeda CA; Paulson H; Barmada S; Sharkey LM
Sci Rep; 2024 Mar; 14(1):6049. PubMed ID: 38472280
[TBL] [Abstract][Full Text] [Related]
20. Mutation-dependent aggregation and toxicity in a Drosophila model for UBQLN2-associated ALS.
Kim SH; Stiles SG; Feichtmeier JM; Ramesh N; Zhan L; Scalf MA; Smith LM; Pandey UB; Tibbetts RS
Hum Mol Genet; 2018 Jan; 27(2):322-337. PubMed ID: 29161404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
